Celularity CEO Robert J. Hariri, M.D., Ph.D., Addresses FII Conference on “The Science and Technology for Extending Healthy Human Lifespan”
Participation in FII is reflective of the Companys focus on global expansion and the importance of Saudi Arabia to the companys strategy.
- Participation in FII is reflective of the Companys focus on global expansion and the importance of Saudi Arabia to the companys strategy.
- Dr. Hariri delivered a presentation titled The Preservation of Human Performance that addressed the cellular and molecular hallmarks of aging and age-related stem cell exhaustion.
- In addition, the Company is actively developing acellular therapeutics for musculoskeletal disease and human performance, and to maintain high performance mobility and aesthetics.
- This effect, according to Dr. Hariri, is evident in age-related conditions such as frailty and age-related muscle loss or sarcopenia.